LATEST UPDATES

Driver killed, 6 injured in Qazigund accident

Precious Kashmir 22/09/2023

J&K police arrests DySP on charges of corruption, fraud & extortion

Indo Asian News Service 21/09/2023

‘Husband allegedly hammers wife to death in Mendhar’

Precious Kashmir 21/09/2023

India suspends visa services for Canadians

Indo Asian News Service 21/09/2023

PM thanks Lok Sabha MPs for passage of Women’s Reservation Bill

Indo Asian News Service 21/09/2023

Biker dies after collision with vehicle in Qazigund

Precious Kashmir 21/09/2023

All vacant posts in Govt departments to be filled within 6 months: LG Manoj Sinha

Precious Kashmir 19/09/2023

Kokernag Gunfight: LeT Commander Uzair Khan Among Two Militants Killed, Searches To Continue: ADGP Kashmir

Precious Kashmir 19/09/2023

Carpenter dies after falling from rooftop in Budgam village

Precious Kashmir 19/09/2023

PM Modi walks to new Parliament building with cabinet colleagues, MPs

Indo Asian News Service 19/09/2023

Groom plays truant on wedding day in Pulwama

Indo Asian News Service 19/09/2023

India expels Canadian diplomat, citing interference concerns

Indo Asian News Service 19/09/2023
  • Home
  • Front
  • Jammu & Kashmir
    • City
  • Anchor stories
  • Business
  • Sports
  • National
  • World
  • Opinion
    • Edit
    • Interviews
    • Letters
  • Epaper
  • Video
Friday, September 22, 2023
PRECIOUS KASHMIR
No Result
View All Result
  • Home
  • Front
  • Jammu & Kashmir
    • City
  • Anchor stories
  • Business
  • Sports
  • National
  • World
  • Opinion
    • Edit
    • Interviews
    • Letters
  • Epaper
  • Video
Precious Kashmir
No Result
View All Result
Home Health

Low dose immunotherapy helpful against head & neck cancers: Bengaluru docs

Indo Asian News Service by Indo Asian News Service
13/09/2023
in Health
2 min read
Site-specific drug delivery for cancer management and treatment
FacebookTwitterWhatsappEmail

Bengaluru: Low dose immunotherapy can be a hope for patients with head and neck cancer by reducing tumours and side effects, according to a pilot study led by doctors at a private hospital here.

The successful pilot study on Low Dose Immunotherapy Nivolumab with neoadjuvant chemotherapy has demonstrated remarkable efficacy and is highly cost-effective, providing an economical therapy option without additional side effects, said doctors at Healthcare Global Cancer Hospital (HCG) Bengaluru on Wednesday.

“Cancer is fast becoming a chronic disease, and a sea change has occurred in how we stage cancer as we adopt a multi-disciplinary approach to
treatment,” said Dr B S Ajaikumar, Executive Chairman of HCG, in a statement.

“This study has the potential to be a game-changer in the sphere of head and neck cancer treatment,” he added.

HCG studied twelve patients of the age group 54 to 76 who experienced significant tumour reduction of over 90 per cent, providing an economical
and side-effect-free therapy through low-dose immunotherapy.

During the study, patients were administered with 40 mg doses every two weeks, as opposed to the full dose of 3 mg per kg of body weight with
standard neoadjuvant chemotherapy, combined with low-dose Nivolumab immunotherapy.

“This study presents a cost-effective solution without compromising the quality of care. This approach not only delivers promising clinical results
but also in a manner that is highly economical for patients,” said Dr Satheesh C T, Consultant – Medical and Hemato Oncology, Director of
Clinical Trials, HCG Cancer Hospital Bangalore.

Head and neck cancer typically consists of anatomical sub sites like tongue, mouth, other parts of the pharynx like oropharynx, nasopharynx,
hypopharynx, salivary glands, nasal cavity, larynx (voice box), etc.

It is a global health issue, comprising 4.5 per cent of total worldwide cancer cases with a mortality rate of 4.6 per cent. The burden is
exceptionally high in Asia.

Moreover, India reports nearly 35 per cent of all cancer cases among individuals aged 40-60.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to print (Opens in new window)

Related

Share196Tweet123SendSend
Indo Asian News Service

Indo Asian News Service

ePAPER

Precious Kashmir

Copyright © 2020 Precious Kashmir.

Navigate Site

  • Home
  • About Us
  • Contact Us
  • Advertise with Us
  • Terms of Service

Follow Us

No Result
View All Result
  • Home
  • Front
  • Jammu & Kashmir
    • City
  • Anchor stories
  • Business
  • Sports
  • National
  • World
  • Opinion
    • Edit
    • Interviews
    • Letters
  • Epaper
  • Video

Copyright © 2020 Precious Kashmir.